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ABSTRACT
Objective To investigate recruitment and retention, data 
collection methods and the acceptability of a ‘within-
consultation’ complex intervention designed to reduce 
antibiotic prescribing.
Design Primary care feasibility cluster randomised 
controlled trial.
Setting 32 general practices in South West England 
recruiting children from October 2014 to April 2015.
Participants Children (aged 3 months to <12 years) with 
acute cough and respiratory tract infection (RTI).
Intervention A web-based clinician-focussed clinical rule 
to predict risk of future hospitalisation and a printed leaflet 
with individualised child health information for carers, 
safety-netting advice and a treatment decision record.
Controls Usual practice, with clinicians recording data on 
symptoms, signs and treatment decisions.
Results Of 542 children invited, 501 (92.4%) consented to 
participate, a month ahead of schedule. Antibiotic prescribing 
data were collected for all children, follow-up data for 495 
(98.8%) and the National Health Service resource use 
data for 494 (98.6%). The overall antibiotic prescribing 
rates for children’s RTIs were 25% and 15.8% (p=0.018) 
in intervention and control groups, respectively. We found 
evidence of postrandomisation differential recruitment: the 
number of children recruited to the intervention arm was 
higher (292 vs 209); over half were recruited by prescribing 
nurses compared with less than a third in the control arm; 
children in the intervention arm were younger (median age 2 
vs 3 years controls, p=0.03) and appeared to be more unwell 
than those in the control arm with higher respiratory rates 
(p<0.0001), wheeze prevalence (p=0.007) and global illness 
severity scores assessed by carers (p=0.045) and clinicians 
(p=0.01). Interviews with clinicians confirmed preferential 
recruitment of less unwell children to the trial, more so in the 
control arm.
Conclusion Differential recruitment may explain the 
paradoxical antibiotic prescribing rates. Future cluster 
level studies should consider designs which remove the 
Strengths and limitations of this study
 ► Recruitment was successful with robust data 
collection and few missing values.
 ► We adequately resourced the trial, achieving 
excellent follow-up with little attrition.
 ► We reduced variation in practice recruitment  levels, 
compared with our previous cohort study.
 ► None of the intervention web  sessions were 
abandoned and clinicians thought it was quick and 
easy to use compared with other interventions.
 ► Clinicians valued the personalised leaflet as an 
alternative to a prescription, although carers were 
less enthusiastic.
 ► The intervention was designed to be used as an 
antibiotic treatment decision aid, but it became 
apparent that some clinicians only used the 
intervention after deciding treatment.
 ► Using the intervention added around 5 min to 
consultation time. Some of this time was to record 
research data and consideration needs to be given 
as to whether these data can be collected outside 
the consultation.
 ► The intervention was a stand-alone system and 
might be more acceptable and easier to use if 
embedded within the existing practice records 
system.
 ► Differential recruitment was quite marked, in 
particular the intervention children were significantly 
more unwell. A future trial design needs to minimise 
or avoid this postrandomisation recruitment bias.
 ► The control clinicians used the same web-based 
data collection system during consultation to record 
study data. Thus, our data collection in the controls 
may have inadvertently increased risk perception as 
well as providing the ‘test’ conditions to encourage 
a Hawthorne effect.
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need for individual consent postrandomisation and embed the intervention 
within electronic primary care records.
Trial registration number ISRCTN 23547970
UKCRN study ID 16891
INTRODUCTION
Respiratory tract infections (RTIs) in children are 
extremely common and costly to service providers, 
families and employers in the UK.1 2 Clinicians often 
prescribe antibiotics ‘just in case’, if they feel uncertain 
about patient health or legal outcomes.3 Clinical uncer-
tainty in primary care regarding the diagnosis and best 
management of RTIs has led to the inappropriate use of 
existing antibiotics, which, combined with the slowing 
in development of new antibiotics, is associated with 
antimicrobial resistance.4–6 This has been described as 
one of the greatest challenges to public health today,7 8 
with the World Economic Forum placing antibiotic-resis-
tant bacteria on the 2014 Global Risks List.9 The 5-year 
National Institute for Health Research (NIHR)-funded 
‘TARGET’ Programme for Applied Research was set up 
in 2010 to derive new knowledge to improve the manage-
ment of antibiotics given to children presenting to 
primary care with RTIs and cough.
Systematic reviews from this programme10 11 found that 
passive strategies targeting only parents, such as waiting 
room posters or pamphlets, do not appear to alter 
prescribing rates significantly. The most effective inter-
ventions involved targeting both parents and clinicians 
during a consultation, using automatic computer prompts 
for evidence-based prescribing, involving clinicians in the 
design of the intervention, using printed materials with 
actionable information and integrating interventions 
into routine clinical processes. Qualitative research found 
that communication within consultations often failed to 
meet parents’ needs: information on symptom relief was 
lacking, safety-netting advice was too vague to be useful 
and parents’ concerns went unaddressed.3 12–15 Clinicians 
revealed that prognostic uncertainty is an important 
driver of antibiotic prescribing, and would like informa-
tion to help them identify the children at risk of future 
illness deterioration.3 16 17
Using a large multicentre, prospective cohort study 
(over 8300 children), we derived and internally validated 
a prognostic rule, using symptoms, signs and demo-
graphic characteristics to predict hospitalisation in the 
following 30 days among children presenting to primary 
care with acute cough and RTI.18 19 Findings from across 
the TARGET programme were synthesised to develop 
a complex intervention, designed to reduce antibiotic 
prescribing. The Children’s Cough (CHICO) feasibility 
trial reported here is the final element of the TARGET 
programme, the aim of which was to assess the recruit-
ment and acceptability of the complex intervention and 
to understand whether it is feasible to conduct a larger 
trial.
METHODS
Design
The CHICO feasibility trial was a primary care cluster 
randomised controlled trial (RCT) comparing a web-based 
intervention with usual care for children presenting to 
general practices with RTI and acute cough. The trial was 
approved by the North West-Haydock Research Ethics 
Committee, UK (reference number: 14/NW/1034, Trial 
registration: ISRCTN23547970, UKCRN study ID: 16891). 
The trial protocol20 was devised according to the SPIRIT 
guidelines21 for RCTs, reporting of the findings followed 
consolidated standards of reporting trials (CONSORT) 
guidelines for clustered trials22 and below is a brief 
summary of the methodology.
Practise and patient recruitment
General practitioners (GPs) were invited to partic-
ipate in the trial from locations in Bristol and the 
surrounding areas; the only exclusion criterion was 
for those few practicses using very outdated internet 
browsers. GPs and prescribing nurses (hereafter termed 
‘clinicians’) were eligible to recruit children to the trial 
and informed consent was obtained from the parent or 
legal guardian (carers). Children were included if they 
were aged between 3 months and under 12 years and 
presenting with an RTI with acute cough of no more 
than 28 days duration prior to consultation. They were 
eligible if they presented with illnesses such as asthma 
(including those with infective exacerbations), epilepsy 
or diabetes. Children who required same day hospital 
assessment or admission were also included. Children 
were excluded if they were considered to have a high 
risk of serious infection (immune-compromised, cystic 
fibrosis, splenectomy).
Randomisation and sample size
The allocation process was a one-off randomisation 
stratified for both practice size and prevalence of anti-
biotic prescribing using a proxy measure of amoxicillin 
suspension prescriptions (the main antibiotic used for 
children with cough) within the previous 12 months. As 
this was a feasibility trial, a formal (effectiveness-based) 
sample size calculation was not required, although 
we were interested in the recruitment rate to inform 
a larger trial design. Recruitment rates varied widely 
between practices in our previous cohort study,19 so 
we monitored recruitment levels closely and capped 
recruitment at no more than 30 patients per practice. 
Estimates from the cohort study suggested 15 practices 
in each arm of the trial would yield a pragmatic sample 
between 300 and 500 patients over a 7-month  period.
Intervention
Intervention development will be described in more 
detail elsewhere, although the paper reporting algo-
rithm development has been published.19 In brief, 
findings from the TARGET programme were synthe-
sised using the Precede-Proceed model of Green and 
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Krueter23 as a framework. The active elements of the 
intervention were determined to be elicitation of 
parents’ concerns, active no-antibiotic messages to 
the clinician, reduction of clinician uncertainty and 
support for a no-antibiotic treatment response. These 
elements were provided using a within-consultation 
interactive web-based tool, which also provided a data 
collection tool. This tool delivered the following inter-
vention elements:
1. Recording children’s symptoms and signs.
2. Elicitation and recording carers’ concerns.
3. For each consultation, children were identified 
as being at very low, normal or high risk of future 
hospitalisation; current National Institute for 
Health and Care Excellence guidelines on antibiotic 
associated with each risk strata were also provided.
4. A personalised printout was produced for carers 
of each child. Clinical observations and carers’ 
concerns recorded in the system were used to 
produce this personalised information leaflet 
that explained the best home-care strategies and 
reinforced important safety netting advice. The 
aim of this leaflet was to give clinicians a tangible 
treatment action other than (or in addition to) 
prescribing, to improve safety-netting information 
and to provide home-care support for carers.
Data collection
Both control and intervention clinicians used the same 
study website to record carers’ consent, enter baseline 
and symptom data during the consultation and record 
their treatment decisions. Additionally, intervention 
clinicians were provided with background information 
about how the risk algorithm was developed, recorded 
carers’ concerns, were given on-screen the future hospi-
talisation risk of the child and provided carers with a 
personalised printout. Use of the intervention was 
assessed by recording the number of times the clinicians 
used the web-based intervention and time spent on each 
page of the website. Follow-up data were collected each 
week from carers until the child’s cough had resolved, 
or up to 8 weeks if not resolved. A medical record notes 
reviews were conducted at the recruiting practices to 
collect data relating to the 30 days following the recruit-
ment consultation, including recruiting consultation 
timings, RTI-related antibiotic prescriptions, reconsul-
tations and RTI-related hospitalisations.
Qualitative interviews
Clinicians from both arms and carers from the inter-
vention arm only were invited to participate in 
semi-structured interviews to explore their views of 
web-based data collection and the intervention. Inter-
views with carers were conducted either in the week 
following recruitment (to facilitate recall of the consul-
tation) or after their child had recovered, to reflect on 
the whole follow-up data collection process. Purposive 
sampling was used to maximise variation in the sample 
of carers, including those with a range of child ages, 
home neighbourhood socioeconomic deprivation, 
illness severity scores and treatment outcomes. Clini-
cians were purposefully sampled to include variation in 
recruiting and prescribing levels.
Health economics
The purpose of the economic analysis was to inform 
the feasibility and design of a within-trial economic 
evaluation alongside a larger RCT, including assessing 
web-based data collection as a means of gathering 
comprehensive resource use and quality of life data 
from carers. We adopted a health system (ie, National 
Health Service (NHS)) perspective for the analysis of 
the costs associated with resource use. We measured 
resources used from the time of recruitment until 
the earliest of either resolution or the end of the 
eighth week of follow-up. Health system resources 
used included GP consultations, use of out-of-hours 
services, NHS 111, walk-in centres and hospital and 
ambulance use. We examined quality of life using 
the Child Health Utility 9D (CHU-9D) instrument, a 
generic measure of paediatric quality of life validated 
for children aged 5–11 years. CHU-9D was included in 
the web-based tool for those children within the valid 
age bracket.
Carers were given the option of providing data using a 
paper version rather than online if preferred. Participants 
were sent text and email reminders followed by tele-
phone calls if the data were not returned promptly.24 25 
The length of the initial consultation was recorded elec-
tronically by the web-based tool and GP practice systems.
Data analysis
Descriptive statistics were used to illustrate the character-
istics of the carers, children and recruiting clinicians. For 
between-arm comparisons, categorical data were tested 
using χ2 or Fisher’s exact test if an expected cell value 
was <5, continuous data were plotted and, if not normally 
distributed, non-parametric tests (Mann-Whitney U test) 
were used. The use of baseline statistical tests to compare 
the arms is legitimate in the context of stratified cluster 
randomisation with subsequent (unconcealed) recruit-
ment of individual participants. Such tests were used to 
ascertain if there was any evidence of differential recruit-
ment of individuals across the trial arms beyond what 
would be expected by chance.
Qualitative interviews were audio-recorded, tran-
scribed, anonymised and imported into NVIVO 10. 
Analysis of qualitative data began shortly after data collec-
tion started and was ongoing and iterative. An inductive 
thematic analysis approach was used to identify patterns 
and themes.26 An initial coding frame was developed and 
refined as new data were produced. Two researchers (CC 
and JH) double coded a subset of transcripts to inform 
the coding framework and ensure robust analysis.27
For both cost and quality of life data, the extent and 
nature of missing data was examined and compared 
between intervention and control practices. Descriptive 
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statistics were used to explore resource use and cost by 
category and by arm to identify important cost  drivers.
RESULTS
Ascertainment and data collection
A total of 32 practices were recruited to the trial, 16 
randomised to each arm. Within the practices, 104 
clinicians signed up as recruiters and 64 recruited at 
least one child (18 nurses and 46 GPs). The target of 
500 recruited children was achieved 1 month ahead of 
schedule (October 2014 to March 2015 inclusive); 542 
children were invited to enter the trial and 501 agreed. Of 
the 41 not included, 18 (3.3%) declined, 19 (3.5%) did 
not meet the eligibility criteria and 2 (0.4%) were subse-
quently withdrawn by the carers. We obtained complete 
carer-reported follow-up data for 495 (98.8%) from the 
501 children retained in the trial. Only two practices 
recruited no children; the median number of children 
recruited at each practices was 16 (range 0–30, IQR 
4–29). Primary care medical record data were collected 
for 100% of the children. Web-based tool information was 
available for all but one of the 501 children.
Sample description
The median age of the 501 children in the trial was 2 
years (IQR: 1–4 years, full range: 3 months to 11 years), 
49% were boys and there was no evidence of a differ-
ence in ethnicity when compared with the 2011 UK 
Census data nor with the prevalence of smoking in the 
household when compared with a 2013 Opinions and 
Lifestyle survey. However, using the postcode of the 
family residence, the median Index of Multiple Depri-
vation score in the trial (12.1) was markedly lower than 
national data (2010 Government statistics), suggesting 
children in this cohort were less deprived than children 
in the general population.
Comparison between study arms
Recruitment
Although there were fewer clinicians in the intervention 
arm (46 vs 58 controls), they recruited 40% more children 
(292 vs 209 children). Table 1 shows a lower proportion 
of control group clinicians recruited children (p=0.02). 
In the intervention arm, a higher proportion of clini-
cians were nurses (28% vs 19% controls), who seemed to 
recruit at a higher rate. More than half the children in 
the intervention arm were recruited by nurses compared 
with less than a third among the controls, although both 
GPs (median 3 children vs 1 among controls, p=0.13) 
and nurses (median 12 children vs 3 among controls, 
p=0.08) in the intervention arm recruited at higher rates 
compared with the controls.
Demographics
There was no marked difference between arms with 
regard to gender, ethnicity or deprivation score (table 2). 
The median age of the children in the intervention 
group was younger compared with the control group (2 
vs 3 years, p=0.03) and the intervention children lived in 
households with proportionally more smokers (29% vs 
17% controls, p=0.002).
Table 1 Comparison of the clinician variables in the two arms of the trial
Control Intervention
n/N or median % or (IQR) n/N or median % or (IQR) p Value
Clinician profile
  Number of GCP trained clinicians 34/58 58.6% 32/46 69.6% 0.25*
  Years since qualified 22 (14–27) 23 (17–27) 0.38†
Clinicians who recruited
  Number of recruiting clinicians 30/58 51.7% 34/46 73.9% 0.021*
  Number of recruiting nurses 7/11 63.6% 11/13 84.6% 0.36‡
  Number of recruiting GPs 23/47 48.9% 23/33 69.7% 0.064*
Number of children recruited by clinician type
  Number of children recruited by nurses 65/209 31.1% 155/292 53.1% <0.001*
  Number of children recruited by GPs 144/209 68.9% 137/292 46.9% <0.001*
Recruitment of children
  Median number of children recruited per clinician 1 (0–4) 3 (0–11) 0.014†
  Median number recruited per nurse 3 (0–7) 12 (3-17) 0.13†
  Median number recruited per GP 0 (0–4) 2 (0–4) 0.077†
*χ2 test.
†Mann-Whitney U test.
‡Fisher’s exact test.
GP, general practitioner.
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Symptoms, signs and health outcomes
The majority of symptoms and signs were more severe 
among the intervention children (table 3) who had a 
longer illness duration prior to consultation (p=0.03), a 
higher respiratory rate (p<0.001), higher wheeze prev-
alence (p=0.007), higher global illness severity scores, 
measured by both the carer (p=0.045) and clinician 
(p=0.02) and children where the clinician had a ‘gut 
feeling’ that something was wrong (p=0.03). There was 
little evidence of a difference between days to cough reso-
lution (median 14 days, IQR 9–25 days in intervention arm 
compared with a median of 13 days, IQR 8–27 days in the 
control arm, p=0.77) or follow-up appointments arranged 
during consultation (primary or secondary: 2.1% vs 1.0% 
controls, p=0.33). There was a slightly higher proportion 
of children in the intervention arm attending emergency 
departments in the 30 days postrecruitment (2.1% vs 
0.5% controls, p=0.14), although none of these children 
Table 2 Demographic profile in each arm of the trial
Control Intervention
Median IQR Median IQR p Value
Child age 3 years 1–5 years 2 years 1–4 years 0.028†
Home IMD* score 12.1 6.9–21.5 12.1 6.5–23.9 0.74†
n/N % n/N %
Gender (male) 105/209 50.2% 139/292 47.6% 0.56‡
Any smoker in household 34/206 16.5% 82/288 28.5% 0.020‡
Ethnicity
White 187/209 89.5% 251/292 86.0% 0.72 (4 df)‡
Mixed 8/209 3.8% 17/292 5.8%
Asian or Asian British 7/209 3.4% 9/292 3.1%
Black or black British 5/209 2.4% 11/292 3.8%
Other ethnic group 2/209 1.0% 4/292 1.4%
*Index of multiple deprivation.
†Mann-Whitney U test.
‡χ2 test.
IMD, Index of Multiple Deprivation.
Table 3 Comparison of children’s symptoms and signs
Control Intervention
Median (IQR) Median (IQR) p Value
Symptom or sign
Illness duration prior to consultation 5 days (3–13) 7 days (4–14) 0.034†
Clinician reported illness severity score (0–10) 3 (2–4) 3 (2–4) 0.022†
Mean SD Mean SD
Carer reported illness severity score (0–10) 4.89 1.75 5.23 1.94 0.045‡
n/N % n/N % §
Severe cough (24 hours prior to consultation) 41/208 19.7% 79/292 27.1% 0.058
Severe fever (24 hours prior to consultation) 15/208 7.2% 26/292 8.9% 0.50
Moderate or severe vomiting (24 hours prior) 18/208 8.7% 41/292 14.0% 0.066
High temperature (≥37.8°C) 29/208 13.9% 29/292 9.9% 0.17
High respiratory rate* 11/208 5.3% 44/292 15.1% <0.001
Intersubcostal recession 5/208 2.4% 11/292 3.8% 0.39
Wheeze (auscultation) 17/208 8.2% 48/292 16.4% 0.007
Crackles or crepitations 37/208 17.8% 65/292 22.3% 0.22
Clinician had ‘gut feeling’ something was wrong 12/208 5.8% 34/292 11.6% 0.025
*Using age-related cut-offs.
†Mann-Whitney U test.
‡T-test.
§χ2 test.
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received antibiotic treatment. There was one hospital 
admission in the 30 days postrecruitment; the child was 
in the intervention arm and was sent home the same day 
with a discharge diagnosis of ‘viral-induced wheeze’.
Antibiotic prescribing
As table 4 shows, in the intervention group of the CHICO 
feasibility trial the overall antibiotic prescribing rate 
at consultation was 25% (19.9% immediate and 5.1% 
delayed)— demonstrating a marked reduction in both 
immediate and delayed prescribing compared with esti-
mates from a few years earlier. However, the prescribing 
rate among the control children in the study was even 
lower (15.8%, 14.4% immediate and 1.4% delayed).
Fidelity and acceptability of the intervention
None of the data collection web sessions during consul-
tation was abandoned and no technical issues were 
Table 4 Antibiotics prescribed at consultation in the two arms of the trial
Prescribing
Control Intervention
N % N % p Value
No antibiotics prescribed 176/209 84.3 219/292 75.0 0.018 (2 df)
Immediate antibiotics prescribed 30/209 14.4 58/292 19.9
Delayed antibiotics prescribed 3/209 1.4 15/292 5.1
Table 5 Description of clinicians and carers sampled for the qualitative analysis
Characteristic N %
Clinician sample
  Total clinicians in sample 28 100%
  Study arm Intervention 16 57.1%
Control 12 42.9%
  Clinician type GP 17 60.7%
Nurse 11 39.3%
  Clinician recruitment rate >20 children 5 17.9%
10–20 children 11 39.3%
<10 children 12 42.9%
  Clinician antibiotic >25% 9 32.1%
  Prescribing rate 15%–24% 9 32.1%
<15% 10 35.7%
Carer sample
  Total carers in sample 14 100%
  IMD quintile* 1 (most deprived) 1 7.1%
2 5 35.7%
3 2 14.3%
4 3 21.4%
5 (most affluent) 3 21.4%
  Child age (in years) <2 8 57.1%
2–4 4 28.6%
5+ 2 14.3%
  Hospitalisation risk Low risk—home care 5 35.7%
  Treatment decision Low risk—delayed antibiotics 3 21.4%
Low risk—immediate antibiotics 1 7.1%
Medium risk—home care 3 21.4%
Medium risk—delayed antibiotics 0 0.0%
Medium risk—immediate antibiotics 2 14.3%
*IMD based on the postcode of the family home.
IMD, Index of Multiple Deprivation.
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reported with the website after resolving early teething 
problems associated with the use of older web-browsers. 
According to the available web page time-stamp data, 
the median time taken to complete the intervention was 
5–6 min. This was consistent with clinicians reporting in 
the interviews that the intervention added 5–10 min onto 
their consultations. Some clinicians said they were reas-
sured that hospitalisation risk agreed with their clinical 
judgement and some felt it was a useful backup for carers. 
The pages describing the background to the trial were 
only accessed on 29 occasions, although we are not able 
to discern whether these were unique visitors, or multiple 
visits from a few clinicians. Clinicians printed the person-
alised leaflet for the majority of the carers (92%), but 
only 4 of the 14 carers interviewed recalled receiving and 
reading the printout. No modifications were made to the 
intervention during the feasibility study.
Qualitative interviews with clinicians and carers
Interviews were conducted with 28 clinicians (17 GPs 
and 11 nurses) and 14 carers sampled with varying char-
acteristics (table 5). Selected quotes from the clinicians 
in each arm of the trial are listed in table 6.
Recruitment
Carers perceived the data burden across the period of 
the study to be light. Clinicians, carers and children all 
liked the recruitment packs, which had been designed 
by a graphic designer, to be colourful and child-
friendly. Clinicians in both arms reported recruiting 
less unwell children, for whom consultations were 
expected to be quicker to treat and therefore easier to 
combine with additional research activity (table 6: Q1). 
Although clinicians commented that the intervention 
was easy and quick to use compared with other studies, 
it still added time to the consultation. Practices with an 
appointment system that channelled eligible children 
towards active recruiters, who were often minor illness 
nurses, had high recruitment rates. In contrast, prac-
tices that normally channelled same-day appointments 
towards particular (non-recruiting) clinicians tended to 
be very low recruiters, despite attempts to get eligible 
patients redirected to recruiters (table 6: Q2).
Using the intervention
Some clinicians in both arms initiated recruitment only 
after they had completed their ‘normal consultation’. 
Most said this was because engaging with the web-based 
tool interfered with their ‘normal consultation’, others 
that they needed to assess the child for serious illness 
before deciding whether to include them in the trial 
(table 6: Q3). Clinicians reported a high degree of 
awareness of the problem of high antibiotic prescribing 
rates and described a range of other concurrent initia-
tives aimed at reducing antibiotic prescribing.
Intervention clinicians rarely reported using the 
CHICO algorithm results as a decision aid. Their 
reasons for this included: i) their ‘normal consultation’ 
including treatment decision was undertaken before 
initiating the intervention; ii) they decided early in the 
consultation that they did not need to prescribe and 
therefore extra information was not useful (table 6: Q4) 
(perhaps exacerbated where they chose not to recruit 
Table 6 Verbatim quotes from the clinicians
Quotes (type of clinician, number, arm of trial)
Q1 ‘if they were quite poorly I wouldn’t be putting them into CHICO, because it would take me um… longer to do that 
consultation and examination and think about the plan of care.’ (NP, #182, Intervention Arm)
Q2 ‘in a busy duty surgery, whilst triaging, would just forget and would book them in as the normal route through the duty 
surgery or with a nurse practitioner. So there were definitely probably children being seen that were missed.’ (GP, #207, 
Control Arm)
Q3 ‘need to examine them first to make sure that they weren’t acutely unwell.’ (GP, #145, Intervention Arm)
Q4 ‘generally by the time you’ve got to that (the odds ratios) you’ve given your advice, haven’t you, and you’ve got a gut 
instinct that actually there isn’t anything wrong with that child.’ (NP, # 162, Intervention Arm)
Q5 ‘I would say that the question that skewed the algorithm the most, in my opinion, was the vomiting one. I think a lot 
of times parents would be over-reporting severity of vomiting. And that’s difficult, I know, because you’re looking for 
subjective data from parents.’ (GP, #133, Intervention Arm)
Q6 ‘I don’t think it influenced me in my antibiotic prescribing at all. … I’m very aware that we over-prescribe, but I think that, 
you know, like I said, I think there are times where I overrode your system regardless.’ (NP, #104, Intervention Arm)
Q7 ‘it was nice to have the reassurance that the algorithm backed me up, if I’d thought that they didn’t need antibiotics…. 
And sometimes I used that to reassure parents as well. But… I knew what I was going to do based on history and 
examination already, as opposed to using the algorithm to dictate my choices of what I was going to do.’ (NP, #133 
Intervention Arm)
Q8 ‘But there were some conflicting things where it said, ‘No antibiotics,’ and I was going to prescribe anyway. So I just 
said, ‘I know it says that, but actually I feel (prescribing antibiotics) is more appropriate,’ for whatever reasons. (GP, #104, 
Intervention Arm)
NP, nurse practitioner; GP, general practitioner.
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sicker children); iii) they lacked trust in the algorithm 
(table 6: Q5). Clinicians said the questions/information 
included in the intervention were more detailed than 
they usually asked, but none felt it had influenced or 
changed their decision. They were reassured when the 
reported risk of hospitalisation agreed with their clin-
ical judgement, and could be used as a useful backup 
to present to carers (table 6: Q7). If the hospitalisation 
risk or advice provided was at odds with their clinical 
judgement, a few clinicians said that they ignored the 
advice (table 6: Q8).
Most carers said the CHICO consultation appeared 
as normal to them, while two said the history taking 
or explanations were more detailed. Few carers were 
aware of the reported risk of hospitalisation or subse-
quent advice from the CHICO intervention; one was 
reassured by the low-risk advice. Two had experiences 
of the clinician prescribing antibiotics despite CHICO 
advice.
The carer leaflet
Clinicians valued having the leaflet to print out for 
carers highly; some said it was a useful alternative to a 
prescription. Some felt it backed up their recommen-
dations and others felt it was good for carers to have 
printed information. Carers had mixed views about 
the leaflet; some felt it did not tell them anything they 
did not know already; others said it gave them some 
useful information; and in one case the carer reported 
that it prevented a reconsultation.
Health economics
The review of patient practice records and the online 
data collection system, supported by telephone calls to 
carers, provided a comprehensive source of information 
on the NHS resource use, although data missingness 
increased with symptom duration. Almost 99% of carers 
reported some NHS resource use. The initial consulta-
tion was estimated to take 15.29 min in the intervention 
arm compared with 10 min in the control arm. Health 
system cost data were positively skewed, reflecting 
limited NHS costs other than for the initial GP consul-
tation.
Mean NHS costs per patient from available cases 
(n=494) were £54.62 in control practices, and £78.78 in 
intervention practices. The difference of £24.15 is asso-
ciated with a bias corrected and accelerated 95% CI of 
£18.57 to £32.98. Mean per-patient costs were primarily 
determined by the costs of the initial consultation, which 
constitute 73% of the NHS costs in the control arm and 
78% in the intervention arm.
Only one in four recruited children were in the age 
range of 5–11 suitable for the CHU-9D instrument; more-
over, only 44 (9% of all participants) provided baseline 
and follow-up data from the week of resolution to facili-
tate the estimation of quality-adjusted life-years. The data 
on these children tentatively suggest that their quality 
of life returned to population norms after the baseline 
appointment, although this finding must be interpreted 
cautiously in light of the limited availability of these data.
DISCUSSION
Summary of main results
The feasibility study showed high recruitment and 
retention. Quantitative and qualitative data confirm the 
intervention was acceptable to the clinicians and widely 
used, but often postconsultation and not within-consulta-
tion as intended. We found evidence of postrandomisation 
differential recruitment, which is likely to have biased our 
estimates of intervention effect and explain our paradox-
ical results.
Evidence for differential recruitment included chil-
dren in the intervention arm having more severe 
baseline characteristics than control children and 
higher recruitment rates in the intervention than 
control arm.
In the qualitative interviews, clinicians from both arms 
of the trial reported preferential recruitment of less 
unwell children as these were quicker to deal with and 
easier to combine with the research. This was particularly 
true in the control arm, where larger numbers of well 
children, relative to the intervention arm, were recruited. 
Evidencing Hawthorne effects (whereby clinicians modi-
fied their behaviour in response to their awareness of 
being in the trial) is challenging in RCTs without concur-
rent observational studies, but our 2011–2013 cohort 
study (in which we developed the algorithm)19 showed 
antibiotic prescribing rates (37%) higher than both our 
intervention (25%) and control (16%) arms. It is there-
fore possible that Hawthorne effects may have been acting 
to reduce prescribing in both arms of our trial. Although 
we did not overtly advertise that the trial was focussing 
on reducing antibiotic prescribing, the clinicians may 
have inferred the aims of the trial. Our previous work 
with these practices may have alerted some clinicians 
to our aims, coupled with national and local campaigns 
to increase awareness of antimicrobial resistance. The 
control clinicians used the same web-based tool during 
consultation to record study data. Thus, our data collec-
tion in itself among the controls may have inadvertently 
increased risk perception (by providing risk information, 
although partially obscured among the data collected 
that was previously unavailable to clinicians) as well as 
provide ‘test’ conditions.
The web-based data collection tool and review of 
medical notes were appropriate vehicles for resource-use 
data collection. The principal driver of higher NHS costs 
in the intervention group was longer initial GP appoint-
ments, when the web-based system was being used. There 
was little evidence on quality of life because of limited 
data availability.
Strengths and weaknesses
There are many strengths to this feasibility trial.
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 ► Recruitment was so rapid that we stopped a month 
earlier than planned, with robust data collection and 
few missing values.
 ► We adequately resourced the trial to achieve 
excellent follow-up with little attrition, building up 
relationships with the families and using several 
types of communication media as an effective way of 
obtaining data for our web-based entry system.
 ► We reduced variation in practice recruitment levels, 
compared with our previous cohort study,19 with a 
higher median number of patients per practice and 
fewer non-recruiting practices.
 ► None of the intervention web-sessions was abandoned 
and clinicians thought it was quick and easy to use 
compared with other interventions.
 ► Clinicians highly valued having the personalised 
leaflet as an alternative to a prescription.
Apart from differential recruitment and potential 
Hawthorne effects, we are aware of three other weak-
nesses.
 ► First, the intervention was designed to be used as 
part of a decision aid, but it became apparent that 
some clinicians only used the intervention after the 
treatment decision was made. The intervention might 
be more acceptable and easier to use if embedded 
within the existing practice records system.
 ► Second, using the intervention added around 
five minutes to consultation time, which could be 
reduced in future. Some of this time was to record 
research data and consideration needs to be given 
as to whether these data can be collected outside 
the consultation either from the medical notes or at 
practice level.
 ► Finally, although clinicians liked the personalised 
leaflets, carers were less enthusiastic. Further 
development through additional parent consultation 
would be recommended for a future trial.
Results in context with other research
We have constructed a complex intervention associated 
with lower antibiotic prescribing rates (from 37% to 
25%) compared with data from similar practices in the 
same area a couple of years earlier,19 but an even lower 
rate among concurrent controls (16%). Local data over a 
4-year period suggest the extremely low prescribing rates 
among the control practices do not reflect usual practice, 
which may be due to differential recruitment.
Antibiotic prescription data from a large primary care 
database, covering 537 UK general practices during 
1995–2011 suggest the rate of prescribing for RTIs in 
children and adults initially fell around the millennium 
but by 2011 had risen to 40%.28 Our estimate of 37% 
among children from a large cohort study conducted 
between 2011 and 201319 is a robust estimate and a 
reduction in prescribing by almost a third to 25% is 
worth pursuing. To do this, a future trial must over-
come the dual problems of differential recruitment and 
Hawthorne effects.
A primary care feasibility trial of patients with back 
pain29 that also experienced differential recruitment 
recommended identifying patients, using independent 
researchers, before randomisation. However, back pain 
is a chronic condition giving research teams time to iden-
tify and invite patient participation. The acute nature of 
childhood respiratory infections prevent prior identifi-
cation and the cost of using independent researchers 
at multiple primary care sites would be prohibitive. 
One approach would be to select primary care sites that 
adopt a triage system for children with cough and work 
more closely with these different systems to help reduce 
selection bias. An alternative would be a ‘lighter touch’ 
design using practice level using routinely collected 
data and practice level consent, negating the need to 
consent and recruit individual patients postrandomisa-
tion. The unit of interest would be the practice rather 
than the patient, so all patients seen in a specified time 
would be included. Amoxicillin suspension is the main 
antibiotic given to children with acute cough and RTI 
and has been successfully used previously30 as a proxy 
marker to assess antibiotic prescribing at the practice 
level.
The Hawthorne effect is not uncommon in clinical 
trials in general or indeed in trials specifically aimed at 
reducing antibiotic prescribing,31 but the mechanisms of 
effect and magnitude are not well understood.32
CONCLUSIONS
Many valuable lessons have been learnt from this feasi-
bility study, and a redesign is required for any future 
trial. To negate differential recruitment and reduce the 
possibility of a Hawthorne effect, a ‘light touch’ effi-
cient design is needed that avoids patient recruitment 
at the clinician level and uses data already routinely 
collected by the practices themselves. Better training 
in the use of the intervention and encouragement to 
use the tool as part of the consultation process would 
be facilitated if the intervention is embedded within 
current practice systems. Removing the need for clini-
cians to recruit patients or enter data other than that 
required for the tool would both reduce the time added 
to consultations and preserve usual practice among the 
control clinicians.
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